Results 211 to 220 of about 3,573,509 (380)
Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor. [PDF]
P N Walsh+4 more
openalex +1 more source
Synthetic cells are engineered herein to respond to an external chemical messenger by the activation of intracellular catalysis. The chemical messenger molecules are catalytically generated by an extracellular enzyme or a mineral surface, whereas the intracellular catalysis emerges via direct enzyme activation or via protein refolding.
Dante G. Andersen+5 more
wiley +1 more source
Evaluating therapeutic plasma exchange and protease inhibitors as mechanisms to reduce soluble mesothelin. [PDF]
Smith KER+6 more
europepmc +1 more source
CD105‐LNPs and PS‐LNPs can deliver α‐lipoic acid to bone marrow mesenchymal stem cells and bone marrow‐derived macrophages, reversing high glucose‐induced oxidative stress while enhancing osteogenesis and M2 polarization. Integrating both nanoparticles into glucose‐responsive hyaluronic acid hydrogel forms DLNPs@HA hydrogel, which accelerates diabetic ...
Yanzhi Zhao+11 more
wiley +1 more source
A multiplex method for rapidly identifying viral protease inhibitors. [PDF]
Hong SJ+23 more
europepmc +1 more source
Strong diuretic effect of pepstatin, an acid protease inhibitor.
Sumio Umezawa+2 more
openalex +2 more sources
Functional Hydrogel for Modulating Lipid Droplets and Neuroinflammation in Head Injury
After TBI, elevated cholesterol levels in activated microglia lead to the accumulation of cholesterol esters in lipid droplets, exacerbating neuroinflammation. A β‐cyclodextrin‐conjugated GelMA (βCD‐GelMA) hydrogel is developed to promotes cholesterol efflux and reduces LDL influx, thereby alleviating intracellular cholesterol and lipid droplet buildup.
Feixiang Chen+9 more
wiley +1 more source
Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax. [PDF]
Alruwaili M+3 more
europepmc +1 more source
Autolysis of stationary phase cells of Bacillus subtilis induced by MAPI, a protease inhibitor.
Sawao Murao+2 more
openalex +2 more sources
Zr‐Fe MOF@Ribociclib@Herceptin (ZFRH) efficiently targets/kills Human Epidermal Growth Factor Receptor 2/Estrogen Receptor‐positive (HER2/ER+) breast cancer cells. It combats tumors by: 1) Elevating ROS, altering redox balance; 2) Inhibiting transcription; 3) Inducing pyroptosis.
Hongkun Miao+8 more
wiley +1 more source